Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Goldberg

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cancer Immunology, Immunotherapy : CII|December 6, 2022
Cxcr3 constrains pancreatic cancer dissemination through instructing T cell fateAdam L Burrack, Ellen J Spartz, Meagan R Rollins, et al.
Neuromuscular Disorders : NMD|February 28, 2025
Obstetric and gynaecological features in females carrying variants in the skeletal muscle ryanodine receptor type 1 (RYR1) gene: a questionnaire studyArti M Mistry, Georgia Saldanha, Luuk R van den Bersselaar, et al.
The Journal of Biological Chemistry|January 9, 2013
Cathepsin-mediated necrosis controls the adaptive immune response by Th2 (T helper type 2)-associated adjuvantsLee S Jacobson, Heriberto Lima, Michael F Goldberg, et al.
Journal of Neuromuscular Diseases|November 21, 2022
RYR-1-Related Diseases International Research Workshop: From Mechanisms to Treatments Pittsburgh, PA, U.S.A., 21-22 July 2022Thomas N O'Connor, Luuk R van den Bersselaar, Yu Seby Chen, et al.
Journal of Neuromuscular Diseases|August 16, 2024
Individuals and Families Affected by RYR1-Related Diseases: The Patient/Caregiver PerspectiveSanne A J H van de Camp, Lizan Stinissen, Andrew Huseth, et al.
Infection and Immunity|January 25, 2017
Identification of Mycobacterial RplJ/L10 and RpsA/S1 Proteins as Novel Targets for CD4<sup>+</sup> T CellsAlison J Johnson, Steven C Kennedy, Cecilia S Lindestam Arlehamn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2018
Suppression of Th1 Priming by TLR2 Agonists during Cutaneous Immunization Is Mediated by Recruited CCR2<sup>+</sup> MonocytesChristopher T Johndrow, Michael F Goldberg, Alison J Johnson, et al.
Nature Medicine|September 6, 2011
A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosisKari A Sweeney, Dee N Dao, Michael F Goldberg, et al.
Immunohorizons|July 30, 2019
Generation of IL-3-Secreting CD4<sup>+</sup> T Cells by Microbial Challenge at Skin and Mucosal BarriersShajo Kunnath-Velayudhan, Michael F Goldberg, Neeraj K Saini, et al.
Immunity|June 23, 2009
Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activationJin S Im, Pooja Arora, Gabriel Bricard, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cancer Immunology, Immunotherapy : CII|December 6, 2022
Cxcr3 constrains pancreatic cancer dissemination through instructing T cell fateAdam L Burrack, Ellen J Spartz, Meagan R Rollins, et al.
Neuromuscular Disorders : NMD|February 28, 2025
Obstetric and gynaecological features in females carrying variants in the skeletal muscle ryanodine receptor type 1 (RYR1) gene: a questionnaire studyArti M Mistry, Georgia Saldanha, Luuk R van den Bersselaar, et al.
The Journal of Biological Chemistry|January 9, 2013
Cathepsin-mediated necrosis controls the adaptive immune response by Th2 (T helper type 2)-associated adjuvantsLee S Jacobson, Heriberto Lima, Michael F Goldberg, et al.
Journal of Neuromuscular Diseases|November 21, 2022
RYR-1-Related Diseases International Research Workshop: From Mechanisms to Treatments Pittsburgh, PA, U.S.A., 21-22 July 2022Thomas N O'Connor, Luuk R van den Bersselaar, Yu Seby Chen, et al.
Journal of Neuromuscular Diseases|August 16, 2024
Individuals and Families Affected by RYR1-Related Diseases: The Patient/Caregiver PerspectiveSanne A J H van de Camp, Lizan Stinissen, Andrew Huseth, et al.
Infection and Immunity|January 25, 2017
Identification of Mycobacterial RplJ/L10 and RpsA/S1 Proteins as Novel Targets for CD4<sup>+</sup> T CellsAlison J Johnson, Steven C Kennedy, Cecilia S Lindestam Arlehamn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2018
Suppression of Th1 Priming by TLR2 Agonists during Cutaneous Immunization Is Mediated by Recruited CCR2<sup>+</sup> MonocytesChristopher T Johndrow, Michael F Goldberg, Alison J Johnson, et al.
Nature Medicine|September 6, 2011
A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosisKari A Sweeney, Dee N Dao, Michael F Goldberg, et al.
Immunohorizons|July 30, 2019
Generation of IL-3-Secreting CD4<sup>+</sup> T Cells by Microbial Challenge at Skin and Mucosal BarriersShajo Kunnath-Velayudhan, Michael F Goldberg, Neeraj K Saini, et al.
Immunity|June 23, 2009
Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activationJin S Im, Pooja Arora, Gabriel Bricard, et al.
Pageof 5